001     277999
005     20260105131056.0
024 7 _ |a pmc:PMC12047270
|2 pmc
024 7 _ |a 10.1101/gr.279414.124
|2 doi
024 7 _ |a pmid:40138663
|2 pmid
024 7 _ |a 1054-9803
|2 ISSN
024 7 _ |a 1088-9051
|2 ISSN
024 7 _ |a 1549-5469
|2 ISSN
024 7 _ |a altmetric:175800512
|2 altmetric
037 _ _ |a DZNE-2025-00526
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Steyaert, Wouter
|0 0000-0001-8393-0788
|b 0
245 _ _ |a Unraveling undiagnosed rare disease cases by HiFi long-read genome sequencing.
260 _ _ |a Stanford, Calif.
|c 2025
|b HighWire Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1745920641_31475
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Solve-RD is a pan-European rare disease (RD) research program that aims to identify disease-causing genetic variants in previously undiagnosed RD families. We utilized 10-fold coverage HiFi long-read sequencing (LRS) for detecting causative structural variants (SVs), single-nucleotide variants (SNVs), insertion-deletions (indels), and short tandem repeat (STR) expansions in previously studied RD families without a clear molecular diagnosis. Our cohort includes 293 individuals from 114 genetically undiagnosed RD families selected by European Reference Network (ERN) experts. Of these, 21 families were affected by so-called 'unsolvable' syndromes for which genetic causes remain unknown and for which prior testing was not a prerequisite. The remaining 93 families had at least one individual affected by a rare neurological, neuromuscular, or epilepsy disorder without a genetic diagnosis despite extensive prior testing. Clinical interpretation and orthogonal validation of variants in known disease genes yielded 12 novel genetic diagnoses due to de novo and rare inherited SNVs, indels, SVs, and STR expansions. In an additional five families, we identified a candidate disease-causing variant, including an MCF2/FGF13 fusion and a PSMA3 deletion. However, no common genetic cause was identified in any of the 'unsolvable' syndromes. Taken together, we found (likely) disease-causing genetic variants in 11.8% of previously unsolved families and additional candidate disease-causing SVs in another 5.4% of these families. In conclusion, our results demonstrate the potential added value of HiFi long-read genome sequencing in undiagnosed rare diseases.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Rare Diseases: genetics
|2 MeSH
650 _ 2 |a Rare Diseases: diagnosis
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Whole Genome Sequencing: methods
|2 MeSH
650 _ 2 |a Polymorphism, Single Nucleotide
|2 MeSH
650 _ 2 |a Genome, Human
|2 MeSH
650 _ 2 |a Pedigree
|2 MeSH
650 _ 2 |a Undiagnosed Diseases: genetics
|2 MeSH
650 _ 2 |a INDEL Mutation
|2 MeSH
700 1 _ |a Sagath, Lydia
|0 0000-0002-6754-3830
|b 1
700 1 _ |a Demidov, German
|b 2
700 1 _ |a Yépez, Vicente A
|b 3
700 1 _ |a Esteve-Codina, Anna
|b 4
700 1 _ |a Gagneur, Julien
|0 0000-0002-8924-8365
|b 5
700 1 _ |a Ellwanger, Kornelia
|b 6
700 1 _ |a Derks, Ronny
|b 7
700 1 _ |a Weiss, Marjan
|b 8
700 1 _ |a den Ouden, Amber
|b 9
700 1 _ |a van den Heuvel, Simone
|b 10
700 1 _ |a Swinkels, Hilde
|b 11
700 1 _ |a Zomer, Nick
|b 12
700 1 _ |a Steehouwer, Marloes
|b 13
700 1 _ |a O'Gorman, Luke
|b 14
700 1 _ |a Astuti, Galuh
|b 15
700 1 _ |a Neveling, Kornelia
|b 16
700 1 _ |a Schüle-Freyer, Rebecca
|0 P:(DE-2719)2812018
|b 17
|u dzne
700 1 _ |a Xu, Jishu
|b 18
700 1 _ |a Synofzik, Matthis
|0 P:(DE-2719)2811275
|b 19
700 1 _ |a Beijer, Danique
|0 P:(DE-2719)9002605
|b 20
|u dzne
700 1 _ |a Hengel, Holger
|b 21
700 1 _ |a Schöls, Ludger
|0 P:(DE-2719)2810795
|b 22
|u dzne
700 1 _ |a Claeys, Kristl G
|b 23
700 1 _ |a Baets, Jonathan
|b 24
700 1 _ |a Van de Vondel, Liedewei
|b 25
700 1 _ |a Ferlini, Alessandra
|b 26
700 1 _ |a Selvatici, Rita
|b 27
700 1 _ |a Morsy, Heba
|b 28
700 1 _ |a Saeed Abd Elmaksoud, Marwa
|b 29
700 1 _ |a Straub, Volker
|0 0000-0001-9046-3540
|b 30
700 1 _ |a Müller, Juliane
|b 31
700 1 _ |a Pini, Veronica
|b 32
700 1 _ |a Perry, Luke
|b 33
700 1 _ |a Sarkozy, Anna
|b 34
700 1 _ |a Zaharieva, Irina
|b 35
700 1 _ |a Muntoni, Francesco
|0 0000-0002-9102-5232
|b 36
700 1 _ |a Bugiardini, Enrico
|0 0000-0002-9709-6699
|b 37
700 1 _ |a Polavarapu, Kiran
|b 38
700 1 _ |a Horvath, Rita
|b 39
700 1 _ |a Reid, Evan
|b 40
700 1 _ |a Lochmüller, Hanns
|b 41
700 1 _ |a Spinazzi, Marco
|0 0000-0003-0048-9558
|b 42
700 1 _ |a Savarese, Marco
|0 0000-0002-2591-244X
|b 43
700 1 _ |a Solve-RD DITF-ITHACA, Solve-RD DITF-Euro-NMD, Solve-RD DITF-RND, Solve-RD DITF-EpiCARE
|b 44
|e Collaboration Author
700 1 _ |a Matalonga, Leslie
|b 45
700 1 _ |a Laurie, Steven
|b 46
700 1 _ |a Brunner, Han G
|b 47
700 1 _ |a Graessner, Holm
|b 48
700 1 _ |a Beltran, Sergi
|b 49
700 1 _ |a Ossowski, Stephan
|0 0000-0002-7416-9568
|b 50
700 1 _ |a Vissers, Lisenka E L M
|0 0000-0001-6470-5497
|b 51
700 1 _ |a Gilissen, Christian
|0 0000-0003-1693-9699
|b 52
700 1 _ |a Hoischen, Alexander
|b 53
700 1 _ |a consortium, Solve-RD
|b 54
|e Collaboration Author
773 _ _ |a 10.1101/gr.279414.124
|g Vol. 35, no. 4, p. 755 - 768
|0 PERI:(DE-600)1483456-X
|n 4
|p 755 - 768
|t Genome research
|v 35
|y 2025
|x 1054-9803
856 4 _ |u https://pub.dzne.de/record/277999/files/DZNE-2025-00526%20SUP.zip
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/277999/files/DZNE-2025-00526.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/277999/files/DZNE-2025-00526.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:277999
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 17
|6 P:(DE-2719)2812018
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 19
|6 P:(DE-2719)2811275
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 20
|6 P:(DE-2719)9002605
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 22
|6 P:(DE-2719)2810795
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-07
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b GENOME RES : 2022
|d 2025-01-07
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0
|0 LIC:(DE-HGF)CCBYNC4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-07
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-07
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-07
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b GENOME RES : 2022
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-07
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 0
920 1 _ |0 I:(DE-2719)5000005
|k AG Schöls
|l Clinical Neurogenetics
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a I:(DE-2719)5000005
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21